glp-1 drugs for addiction Weight-Loss Could Address a Range of Addictions A miracle drug that curbs

A compelling observational study by Goderidze et al

Chhaya Makhija, MD, DipABLM Board-Certified Endocrinologist | Lifestyle Medicine Physician | Founder, Unified Endocrine & Diabetes Care Lafayette Fresno California Telemedicine (including Silicon Valley, Palo Alto, Menlo Park, San Francisco, Walnut Creek, Oakland, Sacramento) Watch or Listen to the Full Episode For a deeper dive into the science and real-world clinical nuance:

however, overall colon transit time was not significantly increased

Improvement in Gastrointestinal Health: BPC-157, with its origins in gastric juice, has demonstrated significant potential in combating and possibly preventing gastrointestinal disorders, including inflammatory bowel disease, Crohns disease, and symptoms of leaky gut

BPC-157's cytoprotective effects are also linked to its interaction with the cellular cytoskeleton

So were going to call this fauxzempic. Thats disingenuous, Dr